Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and ‘salvage’ in patients with high risk locally advanced rectal cancers – tolerance and early outcomes
- DOI
- 10.4103/jcrt.jcrt_225_22
- Published
- 2023-04-07
- Container
- Journal of Cancer Research and Therapeutics
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4103/jcrt.jcrt_225_22,
title = {Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and ‘salvage’ in patients with high risk locally advanced rectal cancers – tolerance and early outcomes},
author = {Ramjas Prajapati and Vikas Ostwal and Sujay Srinivas and Reena Engineer and Prabhat Bhargava and Avanish Saklani and Ashwin D’Souza and Suman Kumar and Zoya Peelay and P. Manali and Anant Ramaswamy},
year = {2023},
journal = {Journal of Cancer Research and Therapeutics},
doi = {10.4103/jcrt.jcrt_225_22},
url = {https://doi.org/10.4103/jcrt.jcrt_225_22}
}RIS
TY - JOUR TI - Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and ‘salvage’ in patients with high risk locally advanced rectal cancers – tolerance and early outcomes AU - Ramjas Prajapati AU - Vikas Ostwal AU - Sujay Srinivas AU - Reena Engineer AU - Prabhat Bhargava AU - Avanish Saklani AU - Ashwin D’Souza AU - Suman Kumar AU - Zoya Peelay AU - P. Manali AU - Anant Ramaswamy PY - 2023 JO - Journal of Cancer Research and Therapeutics DO - 10.4103/jcrt.jcrt_225_22 UR - https://doi.org/10.4103/jcrt.jcrt_225_22 ER -
APA
Prajapati, R., Ostwal, V., Srinivas, S., Engineer, R., Bhargava, P., Saklani, A., D’Souza, A., Kumar, S., Peelay, Z., Manali, P., & Ramaswamy, A. (2023). Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and ‘salvage’ in patients with high risk locally advanced rectal cancers – tolerance and early outcomes. Journal of Cancer Research and Therapeutics. https://doi.org/10.4103/jcrt.jcrt_225_22
Source records
- crossref · retrieved 2026-09-27T14:03:27.030Z